451 related articles for article (PubMed ID: 35865534)
1. GM-CSF: A Double-Edged Sword in Cancer Immunotherapy.
Kumar A; Taghi Khani A; Sanchez Ortiz A; Swaminathan S
Front Immunol; 2022; 13():901277. PubMed ID: 35865534
[TBL] [Abstract][Full Text] [Related]
2. Rational design of granulocyte-macrophage colony-stimulating factor antagonist peptides.
Monfardini C; Kieber-Emmons T; Voet D; Godillot AP; Weiner DB; Williams WV
J Biol Chem; 1996 Feb; 271(6):2966-71. PubMed ID: 8621688
[TBL] [Abstract][Full Text] [Related]
3. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.
O'Mahony DS; Pham U; Iyer R; Hawn TR; Liles WC
Int J Med Sci; 2008 Jan; 5(1):1-8. PubMed ID: 18219369
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-macrophage-colony-stimulating factor and other cytokines: as adjuncts to cancer immunotherapy, stem cell transplantation, and vaccines.
Arellano M; K Waller E
Curr Hematol Rep; 2004 Nov; 3(6):424-31. PubMed ID: 15496276
[TBL] [Abstract][Full Text] [Related]
5. Engineering superactive granulocyte macrophage colony-stimulating factor transferrin fusion proteins as orally-delivered candidate agents for treating neurodegenerative disease.
Heinzelman P; Priebe MC
Biotechnol Prog; 2015; 31(3):668-77. PubMed ID: 25737095
[TBL] [Abstract][Full Text] [Related]
6. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte macrophage colony-stimulating factor has come of age: From a vaccine adjuvant to antiviral immunotherapy.
Petrina M; Martin J; Basta S
Cytokine Growth Factor Rev; 2021 Jun; 59():101-110. PubMed ID: 33593661
[TBL] [Abstract][Full Text] [Related]
8. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
[TBL] [Abstract][Full Text] [Related]
9. Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
Uemura Y; Kobayashi M; Nakata H; Harada R; Kubota T; Taguchi H
Int J Cancer; 2004 May; 109(6):826-32. PubMed ID: 15027115
[TBL] [Abstract][Full Text] [Related]
10. Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.
Bhattacharya P; Budnick I; Singh M; Thiruppathi M; Alharshawi K; Elshabrawy H; Holterman MJ; Prabhakar BS
J Interferon Cytokine Res; 2015 Aug; 35(8):585-99. PubMed ID: 25803788
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor inhibits tumor growth during the postoperative period.
Hill AD; Redmond HP; Naama HA; Bouchier-Hayes D
Surgery; 1996 Feb; 119(2):178-85. PubMed ID: 8571203
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 infection inhibits granulocyte-macrophage colony-stimulating factor-induced activation of STAT5A in human monocyte-derived macrophages.
Warby TJ; Crowe SM; Jaworowski A
J Virol; 2003 Dec; 77(23):12630-8. PubMed ID: 14610185
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation.
Cook AD; Louis C; Robinson MJ; Saleh R; Sleeman MA; Hamilton JA
Arthritis Res Ther; 2016 Dec; 18(1):287. PubMed ID: 27908288
[TBL] [Abstract][Full Text] [Related]
14. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2.
Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H
Oncol Rep; 2007 Apr; 17(4):955-61. PubMed ID: 17342342
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease.
Däbritz J
Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G455-65. PubMed ID: 24503766
[TBL] [Abstract][Full Text] [Related]
16. G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
Martinez Sanz P; van Rees DJ; van Zogchel LMJ; Klein B; Bouti P; Olsman H; Schornagel K; Kok I; Sunak A; Leeuwenburg K; Timmerman I; Dierselhuis MP; Kholosy WM; Molenaar JJ; van Bruggen R; van den Berg TK; Kuijpers TW; Matlung HL; Tytgat GAM; Franke K
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049929
[TBL] [Abstract][Full Text] [Related]
17. Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy.
Thomassen MJ; Ahmad M; Barna BP; Antal J; Wiedemann HP; Meeker DP; Klein J; Bauer L; Gibson V; Andresen S
Cancer Res; 1991 Feb; 51(3):857-62. PubMed ID: 1988125
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and inflammatory stimuli up-regulate secretion of the soluble GM-CSF receptor in human monocytes: evidence for ectodomain shedding of the cell surface GM-CSF receptor alpha subunit.
Prevost JM; Pelley JL; Zhu W; D'Egidio GE; Beaudry PP; Pihl C; Neely GG; Claret E; Wijdenes J; Brown CB
J Immunol; 2002 Nov; 169(10):5679-88. PubMed ID: 12421947
[TBL] [Abstract][Full Text] [Related]
19. Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways.
Uemura Y; Kobayashi M; Nakata H; Kubota T; Bandobashi K; Saito T; Taguchi H
Int J Mol Med; 2006 Aug; 18(2):365-73. PubMed ID: 16820947
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte Macrophage-Colony Stimulating Factor Produces a Splenic Subset of Monocyte-Derived Dendritic Cells That Efficiently Polarize T Helper Type 2 Cells in Response to Blood-Borne Antigen.
Ryu SH; Shin HS; Eum HH; Park JS; Choi W; Na HY; In H; Kim TG; Park S; Hwang S; Sohn M; Kim ED; Seo KY; Lee HO; Lee MG; Chu MK; Park CG
Front Immunol; 2021; 12():767037. PubMed ID: 35069539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
